Tech Insider : Business, Style

In an exclusive interview with Business Insider's Mia de Graaf, Sen. Bernie Sanders talks about his push to improve labels on ultra-processed foods across the US, RFK Jr.'s plans to overhaul the industry, and the obesity epidemic.

Tech Insider
Andrea Javor wearing glasses, a white t-shirt, and jeans sitting on the ground and smiling on the camera while leaning on a bed.
Andrea Javor started doing insulin shots in public.
Tech Insider
A blue eye.
Patients with NAION don't have enough blood flowing to their optic nerve.
Gizmodo

New research released on Wednesday suggests that Ozempic and similar medications may have unexpected side effects. Doctors in Massachusetts have found a link between the drug’s active ingredient semaglutide and a higher risk of a rare condition that can cause blindness called nonarteritic anterior ischemic optic…

Read more...

Gizmodo

The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2 diabetes. Some of these treatments might help people lose even more weight than current forerunners like Novo Nordisk’s semaglutide—the active…

Read more...

Gizmodo

It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a persistent claim made about these drugs that would make any potential user wary: They don’t only help you lose weight—they supposedly…

Read more...